GL1X · GenesisL1 explorer

Research workbench

Structure of bacillus subtilis nitric oxide synthase in complex with ((2S, 3S)-1,3-BIS((6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridin-2- YL)METHOXY)-2-aminobutane

Analyse Structure of bacillus subtilis nitric oxide synthase in complex with ((2S… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LWA
Type
protein
Length
362 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nitric oxide synthase oxygenase
EC
1.14.13.165
UniProt
O34453
Ligands
HEM, Q13, CL
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric oxide synthase oxygenase (EC 1.14.13.165)protein36244% helix, 15% strandO34453

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • Q13 · 6,6'-{[(2S,3S)-2-aminobutane-1,3-diyl]bis(oxymethanediyl)}bis(4-methylpyridin-2-amine) · ligand · chains A
  • CL · Chloride ion · ion · chains A
  • GOL · Glycerol · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16980.780.8352HEM, Q13, CL, GOL
2630.320.7613empty
3780.320.7419empty

Compared structures

  • 4LWA · Structure of Bacillus subtilis nitric oxide synthase in complex with ((2S… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.